Finfeed Archived Mar 24, 2020
The $9.9 million capped Australian-listed Creso Pharma Limited (ASX: CPH) is set to release CBD hemp teas in Q3 2020
Get expert stock analysis direct in your inbox
Join OurMailing List
Discover Small CapBiotech Stocks
Join thousands of other Investors following our stock commentary for Free
